Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Valproic Acid Downregulates Cytokine Expression in Human Macrophages Infected with Dengue Virus
Félix G. Delgado, Paola G Cárdenas, Jaime E. Castellanos
Diseases (2018) Vol. 6, Iss. 3, pp. 59-59
Open Access | Times Cited: 26

Showing 1-25 of 26 citing articles:

Regulation of Chemokines and Cytokines by Histone Deacetylases and an Update on Histone Decetylase Inhibitors in Human Diseases
Himavanth R. Gatla, Nethaji Muniraj, Prashanth Thevkar, et al.
International Journal of Molecular Sciences (2019) Vol. 20, Iss. 5, pp. 1110-1110
Open Access | Times Cited: 82
Potential repurposing of the HDAC inhibitor valproic acid for patients with COVID-19
Bertram Pitt, Nadia R. Sutton, Zhong Wang, et al.
European Journal of Pharmacology (2021) Vol. 898, pp. 173988-173988
Open Access | Times Cited: 43
Epigenetic targeting of the ACE2 and NRP1 viral receptors limits SARS-CoV-2 infectivity
María Laura Sáiz, Marta L. DeDiego, Darío López-García, et al.
Clinical Epigenetics (2021) Vol. 13, Iss. 1
Open Access | Times Cited: 37
Sodium valproate attenuates the iE-DAP induced inflammatory response by inhibiting the NOD1-NF-κB pathway and histone modifications in bovine mammary epithelial cells
Qianyun Gao, Yan Wang, Nana Ma, et al.
International Immunopharmacology (2020) Vol. 83, pp. 106392-106392
Closed Access | Times Cited: 18
SARS-CoV-2 Infection, Sex-Related Differences, and a Possible Personalized Treatment Approach with Valproic Acid: A Review
Donatas Stakišaitis, Linas Kapočius, Angelija Valančiūtė, et al.
Biomedicines (2022) Vol. 10, Iss. 5, pp. 962-962
Open Access | Times Cited: 9
Green synthesis of calcium hydroxide nanoparticles using carob fruit extract and evaluation of their cytotoxic activity
Hajar S. Alayed, Sandhanasamy Devanesan, Mohamad S. AlSalhi, et al.
Applied Nanoscience (2022) Vol. 12, Iss. 8, pp. 2511-2521
Closed Access | Times Cited: 9
Virtual Screening and Molecular Dynamics Simulation Suggest Valproic Acid Co-A could Bind to SARS-CoV2 RNA Depended RNA Polymerase
Neel Sarovar Bhavesh, Anupam Patra
(2020)
Open Access | Times Cited: 13
Improved HDAC Inhibition, Stronger Cytotoxic Effect and Higher Selectivity against Leukemias and Lymphomas of Novel, Tricyclic Vorinostat Analogues
Bartosz Bieszczad, Damian Garbicz, Marta Świtalska, et al.
Pharmaceuticals (2021) Vol. 14, Iss. 9, pp. 851-851
Open Access | Times Cited: 11
Cardiovascular risk in COVID-19 infection.
Valter Lubrano, Silvana Balzan
PubMed (2020) Vol. 10, Iss. 4, pp. 284-293
Closed Access | Times Cited: 7
Therapeutic Use of Valproic Acid and All-Trans Retinoic Acid in Acute Myeloid Leukemia—Literature Review and Discussion of Possible Use in Relapse after Allogeneic Stem Cell Transplantation
Øystein Bruserud, Galina Tsykunova, Maria Hernandez-Valladares, et al.
Pharmaceuticals (2021) Vol. 14, Iss. 5, pp. 423-423
Open Access | Times Cited: 7
Application of multiple omics and network projection analyses to drug repositioning for pathogenic mosquito-borne viruses
Takayuki Amemiya, Katsuhisa Horimoto, Kazuhiko Fukui
Scientific Reports (2021) Vol. 11, Iss. 1
Open Access | Times Cited: 7
Computational approach to decipher cellular interactors and drug targets during co-infection of SARS-CoV-2, Dengue, and Chikungunya virus
Ritu Ghildiyal, Reema Gabrani
VirusDisease (2021) Vol. 32, Iss. 1, pp. 55-64
Open Access | Times Cited: 6
Multi-Tissue Transcriptomic-Informed In Silico Investigation of Drugs for the Treatment of Dengue Fever Disease
Beatríz Sierra, Ana C. Magalhães, Daniel Lemos Soares, et al.
Viruses (2021) Vol. 13, Iss. 8, pp. 1540-1540
Open Access | Times Cited: 4
Serum Levels and in vitro CX3CL1 (Fractalkine), CXCL8, and IL-10 Synthesis in Phytohemaglutinin-Stimulated and Non-stimulated Peripheral Blood Mononuclear Cells in Subjects With Schizophrenia
Jaśmina Arabska, Adam Wysokiński, Ewa Brzezińska‐Błaszczyk, et al.
Frontiers in Psychiatry (2022) Vol. 13
Open Access | Times Cited: 3
Treating post‐dengue mania: Is role of valproate and quetiapine related to histone deacetylase inhibition?
Damodharan Dinakaran, Varshitha Tholasappa, Tshering Lhamu, et al.
Bipolar Disorders (2020) Vol. 22, Iss. 5, pp. 543-545
Closed Access | Times Cited: 3
Targeting histone epigenetics to control viral infections
Zeina Nehme, Sébastien Pasquereau, Georges Herbein
Elsevier eBooks (2020), pp. 255-292
Closed Access | Times Cited: 3
Novel Vorinostat Analogues with Improved HDAC Inhibition, Stronger Cytotoxic Effect and Higher Selectivity Against Leukemias and Lymphomas
Bartosz Bieszczad, Damian Garbicz, Marta Świtalska, et al.
(2021)
Open Access | Times Cited: 3
Valproic acid and bladder healing: an experimental study in rats
Maria de Lourdes Pessole Biondo-Simões, MOACIR OLIVEIRA DALL’ANTONIA, MATHEUS PRINCE GOEHR, et al.
Revista do Colégio Brasileiro de Cirurgiões (2022) Vol. 49
Open Access | Times Cited: 2
Methods of An Open-Label Proof-Of-Concept Trial of Intravenous Valproic Acid for Severe COVID-19
Erwin Chiquete, Liz Toapanta‐Yanchapaxi, Carlos Cantú‐Brito
medRxiv (Cold Spring Harbor Laboratory) (2020)
Open Access | Times Cited: 2
The Antiviral Effects of Sodium Phenylbutyrate Against BoHV-1 Infection In Vitro
Xinye Chen, Guoqiang Zhu, Liqian Zhu
Letters in Drug Design & Discovery (2019) Vol. 16, Iss. 12, pp. 1370-1377
Closed Access | Times Cited: 1
A Novel Artificial Intelligence and Machine learning-based scoring system for evaluating re-purposing potential of Valproic Acid drug in COVID-19.
Akanksha Aggarwal, Robin Sinha, P Preeti, et al.
(2022)
Open Access | Times Cited: 1
Methods of An Open - Label Proof - of - Concept Trial of Intravenous Valproic Acid for Severe COVID-19
Erwin Chiquete, Liz Toapanta‐Yanchapaxi, Carlos Cantú‐Brito
Latin American Journal of Clinical Sciences and Medical Technology (2020) Vol. 2, Iss. 2, pp. 44-48
Open Access | Times Cited: 1
Resveratrol as an epigenetic therapy for flavivirus infection: A narrative review
Kim-Ling Chin, Kim‐Kee Tan, Sazaly Abu Bakar, et al.
Asian Pacific Journal of Tropical Medicine (2023) Vol. 16, Iss. 12, pp. 546-557
Open Access
Transcriptomic Analysis of the Peripheral Immune Cell of SARS-CoV-2 Infected Patients for Bridging the Genotype-Phenotype Gap and Drug Prediction: A Precision Medicine Approach
Arwa Bohra, Shubham Atal, Abhishek Anand, et al.
SSRN Electronic Journal (2022)
Closed Access
HDAC Inhibitors against SARS-CoV-2
Negar Omidkhah, Farzin Hadizadeh, Razieh Ghodsi
Letters in Drug Design & Discovery (2022) Vol. 21, Iss. 1, pp. 2-14
Closed Access
Page 1 - Next Page

Scroll to top